Home » Topics » Conferences

Conferences
RSS

Once-weekly administration of topoisomerase II inhibitor is associated with reduced toxicity

April 14, 1999

Controlled-release formulation of paclitaxel endowed with superior in vivo antitumor activity

April 14, 1999

Angiogenic molecules emerge as an important therapeutic target in cancer

April 14, 1999

Anti-VEGF aptamer is a potent inhibitor of tumor angiogenesis

April 14, 1999

News from AACR: orally active cemadotin analogue from BASF heads for clinic

April 14, 1999

AEterna presents evidence of clinical efficacy of lead MMP inhibitor at AACR meeting

April 14, 1999

4'-Thio-ara-C selected as potential clinical candidate at Southern Research Institute

April 14, 1999

Preclinical studies indicate potential of MMP inhibitor in brain and prostate cancers

April 14, 1999

Novel macrolide antitumor agent in early clinical trials at Wyeth-Ayerst

April 14, 1999

Spotlight on MMP inhibitors in development for cancer

April 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...